Webinars​

The Genetic Disease Screening Program (GDSP) has webinars for its various programs:

• Prenatal Screening Program
  
• Inclusion of Sex Chromosome Aneuploidy Screening to the California Prenatal Screening ​Program​​
  
• ​The California Prenatal Screening Program Town Hall: Adding to the Prenatal Screening Panel
  
• Discussing Genetic Conditions and Screen-Positive Results​
  
• CalGenetic Portal: New Features and Additional Training
• cfDNA Screening: A Clinical Overview​
  

• Newborn Screening Program​
  
• California Newborn Screening Program and Provider Responsibilities
  

​​Prenatal Screening Program​

Inclusion of Sex Chromosome Aneuploidy Screening to the California Prenatal Screening ​Program​ (webinar recorded March 6, 2024)

Webinar Resources

• References (PDF)
  

Presenter Slide Decks

• Prenatal Screening Program Changes, PNS Program Staff (PDF)
• Clinical Overview of cfDNA, Dr. Mary Norton, UCSF, Division Chief, Maternal Fetal Medicine (emailed directly to webinar attendees)
• Prenatal Screening in Practice and Health Equity, Dr. Jasmine Lai, Scripps Clinic, Maternal Fetal Medicine Specialist (PDF, 2.6MB)

If you are having difficulty accessing this content, please contact CDPH at GDSP.Communications@cdph.ca.gov to request this information in an alternate format.​

PNS Program Web Pages

• Information for Providers
  
• Portal Resources​
  ​
  

N​ewborn Screening Program

California Newborn Screening Program and Provider Responsibilities (webinar recorded November 2, 2023)

The California Newborn Screening Program ​and Provider Responsibilities webinar​ was held on Thursday, November 2, 2023, at 5 pm. This webinar presented an overview of the California Newborn Screening Program process, its importance for infant health, key benefits, and the vital role of the prenatal and antenatal primary care provider. 

Continuing medical education (CME) credits are available for viewing this recording. The Genetic Disease Screening Program designates this enduring content (recorded) activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity. The Genetic Disease Screening Program, California Department of Public Health is accredited by the California Medical Association to provide continuing medical education for physicians. None of the faculty, planners, or staff involved with this event have any financial relationships with ineligible companies or commercial interests. This activity did not receive commercial support. Many professional societies and credentialing bodies also accept AMA PRA Category 1 Credits™ for continuing education unit (CEU) requirements (e.g., nursing, genetic counseling, midwifery, social work, physician assistants, etc). To receive CME credit, please complete the enduring content evaluation for this activity after you view the recording. A CME certificate will be emailed to you.​​​